Clinical Trial Update: Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating a thalidomide and hydroxyurea combination in patients with beta-thalassemia has completed enrollment and status. Results a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)
• Thalidomide (thalidomide)

Snippet

Sponsor: Children's Hospital Karachi | Conditions: Thalassemia, Beta | Phase 2, Phase 3 | Status: COMPLETED